10-K: Cartesian Growth II Faces Delisting, Liquidity Concerns

Sentiment:

Annual Report


Cartesian Growth Corporation II filed its annual 10-K report, revealing a Nasdaq delisting, significant shareholder redemptions, and substantial doubt about its ability to continue as a going concern as it approaches its final business combination deadline.

Delay expectedThe company has repeatedly extended its deadline to consummate a business combination, from November 10, 2023, to November 10, 2024 (First Extension), then to November 5, 2025 (Second Extension), and most recently to August 5, 2026 (Third Extension).The Nasdaq delisting was a direct result of the company's failure to complete its initial business combination within 36 months of its IPO registration statement's effectiveness (May 5, 2025).
Capital raiseThe sponsor loaned the company $4,600,000 at no interest simultaneously with the IPO, which can be repaid or converted into sponsor loan warrants.The sponsor issued multiple unsecured promissory notes to the company totaling $2,100,000 in 2025 ($250,000 on May 27, 2025; $250,000 on November 19, 2025; $200,000 on December 29, 2025) and $1,000,000 in 2024, which can be converted into warrants at $1.00 per warrant at the sponsor's discretion upon a business combination.The sponsor also provided funds for monthly extensions through promissory notes: $1,800,000 (First Extension Note) and $2,400,000 (Second Extension Note), deposited into the trust account.The company may seek additional financing (working capital loans) from the sponsor, management team, or other third parties to fund working capital deficiencies or transaction costs, though the sponsor is not obligated to provide such loans.
Worse than expectedThe company was delisted from Nasdaq due to its failure to complete a business combination within the 36-month timeframe.Shareholder redemptions have significantly depleted the trust account, reducing it from $236.9 million to approximately $37.75 million.The company reported a net loss of $1,512,540 for the year ended December 31, 2025, a reversal from the net income of $8,205,527 in 2024.The independent registered public accounting firm's report contains an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern.

Summary

  • Cartesian Growth Corporation II, a blank check company, was incorporated on October 13, 2021, for the purpose of effecting a business combination.
  • The company consummated its Initial Public Offering (IPO) on May 10, 2022, raising $230,000,000 by selling 23,000,000 units at $10.00 per unit.
  • Simultaneously with the IPO, the company sold 8,900,000 private placement warrants for $8,900,000 and received a $4,600,000 loan from its sponsor.
  • A total of $236,900,000 was initially placed in the trust account, with transaction costs amounting to $16,804,728.
  • The company was delisted from Nasdaq on May 13, 2025, due to its failure to complete an initial business combination within 36 months of its IPO registration statement's effectiveness, and its securities are now quoted on the OTC Pink Limited Market.
  • Shareholders approved three extensions, moving the business combination deadline from November 10, 2023, to November 10, 2024 (First Extension), then to November 5, 2025 (Second Extension), and finally to August 5, 2026 (Third Extension).
  • These extensions were accompanied by significant shareholder redemptions: approximately $77.4 million (November 2023), $99,613,642 (November 2024), and $51,219,981.36 (November 2025).
  • As of December 31, 2025, the trust account held $37,914,438, a substantial reduction from its initial balance.
  • The company reported a net loss of $1,512,540 for the year ended December 31, 2025, a decline from a net income of $8,205,527 in 2024.
  • Management has determined that the company's liquidity condition and mandatory liquidation date raise substantial doubt about its ability to continue as a going concern.
  • In October 2024, the company amended its trust agreement to hold funds in an interest-bearing bank demand deposit account instead of U.S. government treasury obligations to mitigate the risk of being deemed an investment company.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as highly negative due to the Nasdaq delisting, significant shareholder redemptions, a net loss, and the explicit "going concern" warning from auditors, indicating severe operational and financial distress for a SPAC nearing its final liquidation deadline.

Positives

  • The management team, affiliated with Cartesian Capital Group, LLC, possesses extensive experience (over 300 years collectively) in international private equity, having executed more than 55 market-leading investments across 30 countries.
  • The sponsor, Cartesian Capital Group, LLC, has managed over $3 billion in committed capital since its inception in 2006.
  • The company's internal control over financial reporting was assessed as effective as of December 31, 2025.

Negatives

  • The company was delisted from The Nasdaq Stock Market on May 13, 2025, due to its failure to complete a business combination within the required 36-month period, and its securities now trade on the less liquid OTC Pink Limited Market.
  • Significant shareholder redemptions occurred in connection with extension votes, reducing the trust account balance from an initial $236.9 million to approximately $37.75 million as of December 31, 2025.
  • The company reported a net loss of $1,512,540 for the year ended December 31, 2025, a reversal from the net income of $8,205,527 in the prior year.
  • The independent registered public accounting firm's report contains an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern.
  • As of December 31, 2025, the company had a working capital deficit of $5,369,032.
  • Moving trust account funds from U.S. government treasury obligations to an interest-bearing demand deposit account may result in less interest earned, potentially reducing the per-share redemption amount for public shareholders.
  • The warrants are accounted for as derivative liabilities, and changes in their fair value can cause significant fluctuations in financial results.

Risks

  • The company is an early-stage entity with no operating history or revenues, providing no basis to evaluate its ability to achieve its business objective.
  • Public shareholders may not have an opportunity to vote on the proposed business combination, as the board may complete it without shareholder approval.
  • Third-party claims against the company could reduce the proceeds held in the trust account, potentially leading to a per-share redemption amount less than $10.30.
  • The ability of public shareholders to redeem their shares for cash may make the company's financial condition unattractive to potential business combination targets.
  • The requirement to complete a business combination by August 5, 2026, may give potential target businesses leverage in negotiations.
  • Global economic conditions, geopolitical conflicts (e.g., Ukraine-Russia, Israel-Hamas), and inflation may adversely affect the search for and consummation of a business combination.
  • Failure to complete an initial business combination by August 5, 2026, will result in liquidation, with public shareholders receiving approximately $10.30 per share (or less in certain circumstances) and warrants expiring worthless.
  • Insufficient funds outside the trust account may hinder operations until the business combination deadline, requiring reliance on sponsor loans which are not guaranteed.
  • Resources may be wasted on researching acquisitions that are not completed, adversely affecting subsequent attempts.
  • Limited ability to assess the management of prospective target businesses could lead to an unsuccessful post-combination entity.
  • Key personnel of an acquisition candidate may resign upon completion of the business combination, negatively impacting operations.
  • Potential conflicts of interest exist due to the sponsor's, officers', and directors' affiliations with other entities and their financial interest in completing a business combination.
  • The company may issue notes or other debt securities to complete a business combination, adversely affecting its leverage and financial condition.
  • Completing only one business combination may lead to a lack of diversification and increased exposure to risks of a single business.
  • Acquiring a private company with limited available information carries the risk of the target being less profitable than anticipated.
  • Pursuing complex business combination opportunities requiring significant operational improvements could delay or prevent desired results.
  • Effecting a business combination with a non-U.S. business introduces additional risks, including currency fluctuations, differing legal systems, and enforcement challenges.
  • Re-domiciling to another foreign jurisdiction could result in taxes imposed on shareholders.
  • Unfamiliarity of new management with U.S. securities laws post-business combination could lead to regulatory issues.
  • Increased competition from other SPACs may make attractive targets scarcer and increase acquisition costs.
  • Management may not be able to maintain control of a target business after the initial business combination.
  • Changes in the market for directors and officers liability insurance could make it more difficult and expensive to complete a business combination.
  • The absence of a specified maximum redemption threshold means a business combination could be completed even if a substantial majority of shareholders disagree.
  • Provisions in the company's constitutional documents may inhibit a takeover.
  • A lower amendment threshold for constitutional documents and the trust agreement (65% of public warrants for warrant terms, 2/3 majority for articles) makes it easier to amend terms, potentially against shareholder interests.
  • The company may be unable to obtain additional financing to complete a business combination or fund the operations and growth of a target business.
  • Outstanding warrants may have an adverse effect on the market price of Class A ordinary shares and make a business combination more difficult.
  • Warrants are accounted for as liabilities, and changes in their fair value could materially affect financial results.
  • A specific provision in the warrant agreement may make it more difficult to complete a business combination if certain price conditions are met.
  • Shareholders may not have the opportunity to appoint directors or discuss company affairs until after a business combination.
  • The requirement to furnish target business financial statements may limit the pool of potential targets.
  • Compliance obligations under the Sarbanes-Oxley Act may increase the time and costs of completing an acquisition.
  • As a Cayman Islands exempted company, investors may face difficulties in protecting their interests and enforcing rights through U.S. federal courts.
  • There is uncertainty regarding the applicability of the Investment Company Act of 1940, which could severely restrict activities or lead to liquidation.
  • The company may be a passive foreign investment company (PFIC), resulting in adverse U.S. federal income tax consequences for U.S. investors.
  • Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and/or financial loss.

Future Outlook

The company must consummate an initial business combination by August 5, 2026. If a business combination is not completed by this date, the company will cease all operations except for winding up, redeem its public shares, and liquidate. The company anticipates incurring significant costs in its acquisition efforts and cannot guarantee success. Its ability to complete a business combination may be negatively impacted by general market conditions, capital and debt market volatility, and ongoing geopolitical conflicts.

Management Comments

  • "We believe our team has the required analytic, financial, and operational expertise to complete a successful initial business combination and generate attractive risk-adjusted returns for our shareholders."
  • "We believe that our management team’s cycle-tested and distinctive investment approach will contribute to a successful initial business combination and the continued development of the combined company."
  • "We believe that the funds available to us outside of the trust account, together with funds available from loans from our sponsor will be sufficient to allow us to operate until at least the Extended Date; however, we cannot assure you that our estimate is accurate."

Industry Context

StockSavvy.ai notes that Cartesian Growth Corporation II's situation reflects the increasing challenges faced by many Special Purpose Acquisition Companies (SPACs) in a volatile market. The delisting from Nasdaq and subsequent trading on the OTC Pink market, coupled with significant shareholder redemptions, highlight the difficulty in identifying and closing suitable business combinations within mandated timelines, especially amidst global economic uncertainties and increased competition for attractive targets. The shift of trust account funds to a demand deposit account also indicates a broader industry response to regulatory concerns regarding SPAC investment company status.

Comparison to Industry Standards

  • The company's delisting from Nasdaq due to failure to complete a business combination within 36 months is a significant underperformance compared to successful SPACs that complete mergers and transition to operating companies on major exchanges.
  • The substantial shareholder redemptions (over 80% of initial public shares redeemed) are significantly higher than the average redemption rates seen in successful SPAC mergers, indicating a strong lack of shareholder confidence in the company's ability to find a suitable target or the terms of proposed extensions.
  • The ongoing "going concern" doubt, as highlighted by auditors, is a critical red flag, contrasting sharply with the financial stability expected of operating companies or well-capitalized SPACs nearing a definitive agreement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Charter AmendmentShareholders approved the First Extension Charter Amendment on November 6, 2023, extending the business combination deadline to November 10, 2024.November 6, 2023Extended the period for the company to find a business combination, but also led to significant shareholder redemptions.
Trust Agreement AmendmentThe Investment Management Trust Agreement was amended on October 7, 2024, to permit holding funds in an interest-bearing bank demand deposit account instead of U.S. government treasury obligations.October 7, 2024Aimed to mitigate the risk of being deemed an investment company under the Investment Company Act of 1940, but may result in less interest earned on trust account funds.
Charter AmendmentShareholders approved the Second Extension Charter Amendment on November 6, 2024, extending the business combination deadline to November 5, 2025.November 6, 2024Further extended the search period, but resulted in another round of substantial shareholder redemptions.
Charter AmendmentShareholders approved an amendment on November 6, 2024, to eliminate the limitation that would prevent redemption of Class A ordinary shares if it resulted in failure to have net tangible assets of at least $5,000,001 upon consummation of an initial business combination.November 6, 2024Removed a potential barrier to redemptions, potentially making it easier for shareholders to exit, but also reducing the capital available for a business combination.
Charter AmendmentShareholders approved the Third Extension Charter Amendment on November 3, 2025, extending the business combination deadline to August 5, 2026.November 3, 2025Provided a final extension for the company to complete a business combination, but was followed by additional significant redemptions, further depleting the trust account.

Related Party Transactions

  • On October 20, 2021, the sponsor and DirectorCo purchased 5,750,000 founder shares for a total subscription price of $25,000.
  • The sponsor, Cantor Fitzgerald & Co., and Piper Sandler & Co. purchased an aggregate of 8,900,000 private placement warrants for $8,900,000 simultaneously with the IPO.
  • The sponsor loaned the company $4,600,000 at no interest simultaneously with the IPO (Sponsor Loan), which can be repaid or converted into sponsor loan warrants.
  • The company agreed to pay an affiliate of its sponsor up to $10,000 per month for office space, utilities, secretarial support, and administrative services, commencing May 5, 2022.
  • The sponsor issued multiple unsecured promissory notes to the company: $500,000 (Oct 2023), $250,000 (Jan 2024), $250,000 (Jul 2024), $250,000 (Nov 2024), $250,000 (Dec 2024), $250,000 (May 2025), $250,000 (Nov 2025), and $200,000 (Dec 2025). These notes do not bear interest and are convertible into warrants at $1.00 per warrant at the sponsor's discretion upon a business combination.
  • In connection with the First Extension, the company issued an unsecured promissory note (First Extension Note) for up to $1,800,000 to the sponsor, from which $1,800,000 was drawn and deposited into the trust account.
  • In connection with the Second Extension, the company issued an unsecured promissory note (Second Extension Note) for up to $2,400,000 to the sponsor, from which $2,400,000 was drawn and deposited into the trust account.
  • The sponsor, an affiliate of the sponsor, or certain officers and directors may provide working capital loans to finance transaction costs, up to $1,500,000 of which may be convertible into warrants.
  • The sponsor, Cantor Fitzgerald & Co., Piper Sandler & Co., and their permitted transferees have registration rights for founder shares, private placement warrants, sponsor loan warrants, and Class A ordinary shares issuable upon their exercise.

Stakeholder Impact

  • Shareholders face significant risk of capital loss, as the company's warrants will expire worthless if a business combination is not completed by August 5, 2026. Those who have not redeemed their shares may receive less than the initial $10.30 per share upon liquidation due to potential claims against the trust account.
  • The substantial redemptions have diluted the ownership and influence of remaining public shareholders and reduced the capital available for a potential business combination.
  • The sponsor and management team have a strong financial incentive to complete a business combination to avoid their founder shares and private placement warrants becoming worthless, potentially creating conflicts of interest.
  • Creditors face the risk that claims against the company could reduce the funds available in the trust account, potentially impacting the per-share redemption amount for public shareholders, although the sponsor has agreed to indemnify the company for certain claims.

Next Steps

  • Consummate an initial business combination by the extended deadline of August 5, 2026.
  • If a business combination is not completed by August 5, 2026, the company will cease operations, redeem public shares, and liquidate.
  • Continue to identify and evaluate target businesses for a potential business combination.
  • Manage ongoing operating costs and seek additional financing if necessary to fund operations until a business combination is completed or liquidation occurs.

Key Dates

DateDescription
October 13, 2021Company incorporated as a Cayman Islands exempted company.
October 20, 2021Sponsor and DirectorCo purchased 5,750,000 founder shares for $25,000.
May 5, 2022IPO registration statement became effective; Administrative Services Agreement, Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and Promissory Note for Sponsor Loan were dated.
May 10, 2022Consummated IPO of 23,000,000 units at $10.00 per unit, generating $230,000,000 gross proceeds. Simultaneously sold 8,900,000 private placement warrants for $8,900,000 and received a $4,600,000 loan from the sponsor.
September 22, 2023Sponsor and DirectorCo converted 5,749,998 Class B ordinary shares into an equal number of Class A ordinary shares.
October 12, 2023Issued an unsecured promissory note to the Sponsor for $500,000.
November 6, 2023Shareholders approved the First Extension Charter Amendment, extending the business combination deadline to November 10, 2024. Holders of 7,129,439 Class A ordinary shares redeemed for approximately $77.4 million. Issued an unsecured promissory note (First Extension Note) for up to $1,800,000 to the Sponsor.
December 6, 2023Board approved the second one-month extension of the Business Combination Period.
January 8, 2024Board approved the third one-month extension of the Business Combination Period.
January 19, 2024Issued an unsecured promissory note to the Sponsor for $250,000.
February 5, 2024Board approved the fourth one-month extension of the Business Combination Period.
March 5, 2024Board approved the fifth one-month extension of the Business Combination Period.
April 9, 2024Board approved the sixth one-month extension of the Business Combination Period.
May 6, 2024Board approved the seventh one-month extension of the Business Combination Period.
June 5, 2024Board approved the eighth one-month extension of the Business Combination Period.
July 9, 2024Board approved the ninth one-month extension of the Business Combination Period.
July 12, 2024Issued an unsecured promissory note to the Sponsor for $250,000.
August 6, 2024Board approved the tenth one-month extension of the Business Combination Period.
September 5, 2024Board approved the eleventh one-month extension of the Business Combination Period.
October 7, 2024Board approved the twelfth one-month extension of the Business Combination Period. The Investment Management Trust Agreement was amended to permit holding funds in an interest-bearing bank demand deposit account, and funds were moved from Treasury Obligations.
November 6, 2024Shareholders approved the Second Extension Charter Amendment, extending the business combination deadline to November 5, 2025. Holders of 8,620,849 Class A ordinary shares redeemed for $99,613,642. Issued an unsecured promissory note (Second Extension Note) for up to $2,400,000 to the Sponsor. Shareholders also approved an amendment to eliminate the redemption limitation.
December 2, 2024Company approved the second one-month extension of the Business Combination Period under the Second Extension.
December 16, 2024Issued an unsecured promissory note to the Sponsor for $250,000.
December 31, 2024Company approved the third one-month extension of the Business Combination Period under the Second Extension.
January 31, 2025Company approved the fourth one-month extension of the Business Combination Period under the Second Extension.
February 28, 2025Company approved the fifth one-month extension of the Business Combination Period under the Second Extension.
April 1, 2025Company approved the sixth one-month extension of the Business Combination Period under the Second Extension.
May 1, 2025Company approved the seventh one-month extension of the Business Combination Period under the Second Extension.
May 6, 2025Received a letter from Nasdaq stating that the company's securities would be delisted.
May 13, 2025Company's securities suspended trading on Nasdaq.
May 27, 2025Issued an unsecured promissory note to the Sponsor for $250,000. Company approved the eighth one-month extension of the Business Combination Period under the Second Extension.
June 30, 2025Company approved the ninth one-month extension of the Business Combination Period under the Second Extension.
July 15, 2025Nasdaq filed a Form 25-NSE, delisting the company's securities from the exchange. Securities began quoting on the OTC Pink Limited Market.
August 1, 2025Company approved the tenth one-month extension of the Business Combination Period under the Second Extension.
September 2, 2025Company approved the eleventh one-month extension of the Business Combination Period under the Second Extension.
October 1, 2025Company approved the twelfth one-month extension of the Business Combination Period under the Second Extension.
November 3, 2025Shareholders approved the Third Extension Charter Amendment, extending the business combination deadline to August 5, 2026. Holders of 4,173,618 Class A ordinary shares redeemed for $51,219,981.36.
November 19, 2025Issued an unsecured promissory note to the Sponsor for $250,000.
December 29, 2025Issued an unsecured promissory note to the Sponsor for $200,000.
December 31, 2025Fiscal year ended.
March 31, 2026Date of filing of the Annual Report on Form 10-K.
August 5, 2026Extended deadline to consummate an initial business combination.

Recommendation

strong sell

The company faces imminent liquidation if it fails to secure a business combination by August 5, 2026, a highly uncertain prospect given its Nasdaq delisting, massive shareholder redemptions, and explicit "going concern" warning. The significant depletion of the trust account and ongoing net losses further underscore the severe financial distress and lack of a viable path forward, making the stock a high-risk, low-reward investment.

Keywords

SPAC, blank check company, business combination, delisting, Nasdaq, OTC Pink, shareholder redemptions, going concern, trust account, warrants, financial reporting, SEC filing, Cayman Islands, private equity, Cartesian Growth Corporation II

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.